In September, 2018, the U.S. Drug Enforcement Administration announced that certain drug products that have been approved by the Food and Drug Administration (FDA) and which contain cannabidiol (CBD) will be considered Schedule V drugs. Specifically, this order places FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols in schedule V.
So for CBD products from hemp, check labels to see whether they say where it was grown, and look especially for those from Colorado. Not all products, however, include that information. So in a dispensary or a retail store, ask the staff whether they know where the hemp was grown. And for products purchased online, check the companies' website to see whether it has that information, or contact the seller to ask the same question.
The heat is very much on CBD oil sellers these days as the FDA continues to crack down on companies selling “questionable” (to put it nicely) hemp-based products. In fact, since 2015 – when the FDA first issued warning letters to multiple CBD sellers – the industry has been forced to clean up its act, at least in terms of manufacturing operations and brand transparency.